ProfileGDS4718 / 215336_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 65% 57% 46% 61% 60% 62% 62% 57% 62% 63% 54% 58% 57% 69% 64% 59% 57% 68% 63% 63% 55% 59% 59% 59% 59% 64% 65% 79% 67% 60% 59% 64% 56% 60% 68% 67% 54% 62% 58% 49% 61% 66% 59% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4514465
GSM549102patient 115, normal, homogenized [OPG study]5.9698957
GSM549104patient 119, normal, homogenized [OPG study]5.3117246
GSM549108patient 138, normal, homogenized [OPG study]6.2050961
GSM549119patient 077, normal, homogenized [OPG study]6.1539660
GSM549133patient 032, cancer, homogenized [OPG study]6.2677162
GSM549139patient 042, cancer, homogenized [OPG study]6.2737362
GSM549099patient 107, normal, homogenized [OPG study]5.9162757
GSM549109patient 139, normal, homogenized [OPG study]6.2534262
GSM549110patient 046, normal, homogenized [OPG study]6.2956263
GSM549114patient 063, normal, homogenized [OPG study]5.7167354
GSM549122patient 082, normal, homogenized [OPG study]5.9866158
GSM549134patient 033, cancer, homogenized [OPG study]5.9321457
GSM549136patient 036, cancer, homogenized [OPG study]6.8106569
GSM549140patient 044, cancer, homogenized [OPG study]6.3915264
GSM549111patient 047, normal, homogenized [OPG study]6.0426159
GSM549113patient 057, normal, homogenized [OPG study]5.8877557
GSM549132patient 031, cancer, homogenized [OPG study]6.7371168
GSM549137patient 038, cancer, homogenized [OPG study]6.3525363
GSM549142patient 047, cancer, homogenized [OPG study]6.3664163
GSM549100patient 110, normal, homogenized [OPG study]5.8363655
GSM549107patient 135, normal, homogenized [OPG study]6.0543659
GSM549115patient 068, normal, homogenized [OPG study]6.0227859
GSM549116patient 072, normal, homogenized [OPG study]6.0680959
GSM549120patient 078, normal, homogenized [OPG study]6.0521659
GSM549131patient 030, cancer, homogenized [OPG study]6.4351664
GSM549118patient 074, normal, homogenized [OPG study]6.5027865
GSM549129patient 027, cancer, homogenized [OPG study]7.7731779
GSM549123patient 088, normal, homogenized [OPG study]6.6590267
GSM549124patient 006, cancer, homogenized [OPG study]6.123760
GSM549126patient 015, cancer, homogenized [OPG study]6.0583559
GSM549128patient 025, cancer, homogenized [OPG study]6.4297864
GSM549103patient 117, normal, homogenized [OPG study]5.9184256
GSM549117patient 073, normal, homogenized [OPG study]6.080360
GSM549138patient 041, cancer, homogenized [OPG study]6.7271368
GSM549141patient 045, cancer, homogenized [OPG study]6.682567
GSM549130patient 028, cancer, homogenized [OPG study]5.7641854
GSM549101patient 111, normal, homogenized [OPG study]6.3182962
GSM549105patient 128, normal, homogenized [OPG study]6.0119558
GSM549106patient 134, normal, homogenized [OPG study]5.429949
GSM549112patient 048, normal, homogenized [OPG study]6.1497361
GSM549125patient 011, cancer, homogenized [OPG study]6.5441966
GSM549127patient 024, cancer, homogenized [OPG study]6.1094559
GSM549135patient 035, cancer, homogenized [OPG study]6.259762